Valiant Laboratories Limited (NSE:VALIANTLAB)
54.08
-2.25 (-3.99%)
Mar 12, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 2.94 billion as of March 12, 2026. Its market cap has decreased by -27.93% in one year.
Market Cap
2.94B
Enterprise Value
2.85B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
54.08
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 2.94B, a decrease of -60.29%. That is a compound annual growth rate of -31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 2.94B | -22.74% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 12.38B |
| Sakar Healthcare | 12.36B |
| Jagsonpal Pharmaceuticals | 12.00B |
| Beta Drugs | 11.41B |
| Sigachi Industries | 7.43B |
| Bafna Pharmaceuticals | 2.49B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.79B |